Markers of inflammation in exhaled breath condensate and bronchoalveolar lavage fluid Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007
Is analysis of exhaled breath condensate equivalent to that of bronchoalveolar lavage fluid? Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011
Markers of fibrosis in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) in sarcoidosis Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008
The physiological concentration of nitrite in exhaled breath condensate, broncho-alveolar lavage fluid and blood samples Source: Eur Respir J 2004; 24: Suppl. 48, 402s Year: 2004
Nasal lavage cysteinyl-leukotrienes correlate with exhaled breath condensate in children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006
Cytokine and chemokine composition of bronchoalveolar lavage fluid and exhaled breath condensate of healthy individuals Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
Indices of oxidative stress in a feline model of asthma: 8-Iso-PGF2α in bronchoalveolar lavage and H2 O2 in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 680s Year: 2004
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults Source: Eur Respir J 2007; 30: 769-781 Year: 2007
Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Cardiopulmonary bypass (CPB) induced lung inflammation is better detected by bronchoalveolar lavage (BAL) fluid than by exhaled breath condensate (EBC) Source: Eur Respir J 2003; 22: Suppl. 45, 380s Year: 2003
BAL and exhaled breath condensate in children: Is there any relationship between these fluids? Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
Inflammatory mediators in exhaled breath condensate, induced sputum and saliva Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004
Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004
Exhaled 8-isoprostane in sarcoidosis. Relation to superoxide anion production by bronchoalveolar lavage cells Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate Source: International Congress 2014 – Airway biomarkers Year: 2014
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 369s Year: 2006
LTB4 in expired breath condensate and sputum supernatant in patients with COPD. The effects of reversibility Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003